Examining the Efficacy of the Man Therapy Platform in Reducing Problematic Anger Among Military S… (NCT07604701) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Examining the Efficacy of the Man Therapy Platform in Reducing Problematic Anger Among Military Service Members With and Without a TBI History
United States226 participantsStarted 2026-09-01
Plain-language summary
The goal of this randomized controlled trial is to determine if an interactive digital solution, Man Therapy, reduces indices of problematic anger in male military service members who screen positive for problematic anger.
The man questions this study aims to answer are:
* Does Man Therapy reduce indices of problematic anger?
* Does Man Therapy reduce psychosocial correlates of anger?
Researchers will also examine if the effects of those aims differ based on a participant's history of a mild TBI, the mechanism of a primary mild TBI, and/or the number of mild TBIs.
Researchers will compare Man Therapy to a waitlist control. This will help determine if Man Therapy works better than no treatment.
Participants will:
* Complete a baseline survey
* Be randomized to intervention or waitlist control
* If randomized to intervention, participants will receive the intervention and complete a survey immediately after the intervention and at 1-, and 3-months following the intervention
* If randomized to waitlist control, participants complete surveys at 1-, and 3-months and have the opportunity to complete the intervention following the 3-month survey
Who can participate
Age range
18 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Military service member
* Identify as male
* Aged 18+ years
* Positive problematic anger screen (DAR-3 \>8)
* Ability to read, write, and speak English
Exclusion Criteria:
* Active psychosis or acute mania necessitating clinical intervention
* Acute thoughts of self- or other-harm necessitating imminent clinical intervention (e.g., hospitalization)
* Unable to provide informed consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial uses an online platform called Man Therapy — how does that work in practice, and do you think a self-guided digital tool is realistic for where I am right now with my anger and TBI symptoms?
2The trial isn't recruiting yet — given my current situation, is it worth waiting for this study to open, or should we be looking at treatments that are available to me right now?
3The study is measuring anger using a specific questionnaire called the STAXI-2 — based on how you'd score my anger symptoms, do you think I'd even be a good fit for what this trial is trying to study?
4Since this trial is listed as Phase NA, which often means it's testing a behavioral or digital tool rather than a drug, what do we actually know — or not know yet — about how safe and effective the Man Therapy platform is for people with a TBI history like mine?
5If I do eventually look into enrolling, would my TBI history put me in a different group than someone without a TBI, and could that affect what kind of support or outcomes I might expect from participating?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
State Anger (S-Anger) Subscale as Measured by State-Trait Anger Expression Inventory-2 (STAXI-2)
Timeframe: From enrollment to the completion of a 3-month follow-up assessment.